Insights from 2024 ASCO® GU Annual Meeting
Playback speed
10 seconds
ASCO® GU 2024 Insights: "Subgroup Analyses of Efficacy Outcomes by Baseline Tumor Size in the CLEAR Trial - Lenvatinib & Pembro in 1L Treatment of aRCC"
87 views
March 5, 2024
Comments 0
Login to view comments.
Click here to Login
Videos